Cargando…

Quantitative differences in antibody responses between normal donors HAM/TSP patients, asymptomatic carriers, and ATL patients from Jamaica: can they be used to estimate risk of disease?

Detalles Bibliográficos
Autores principales:	Akahata, Yoshimi, Abrams, Anna, Goedert, James, Maloney, Elizabeth, Jacobson, Steven
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Meeting Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3112577/ http://dx.doi.org/10.1186/1742-4690-8-S1-A110

Ejemplares similares

Lack of recall response to Tax in ATL and HAM/TSP patients but not in asymptomatic carriers of human T-cell leukemia virus type 1
por: Manuel, Sharrón L, et al.
Publicado: (2014)

Role of HTLV-1 Tax and HBZ in the Pathogenesis of HAM/TSP
por: Enose-Akahata, Yoshimi, et al.
Publicado: (2017)

Using a sensitive luciferase immunoprecipitation system (LIPS) to detect HTLV-I/II seroindeterminates in Jamaica
por: Akahata, Yoshimi, et al.
Publicado: (2011)

HAM/TSP in relatives of HAM/TSP cases and in relatives of asymptomatic HTLV-1 carriers
por: Alvarez, Carolina, et al.
Publicado: (2014)

Immunovirological markers in HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP)
por: Enose-Akahata, Yoshimi, et al.
Publicado: (2019)

Opposite effect of Valproate on Tax and HBZ expression in T-lymphocytes from HTLV-1 asymptomatic carriers and HAM/TSP patients
por: Belrose, Gildas, et al.
Publicado: (2011)

Correlation of increased CXCL13 with intrathecal humoral immune responses to HTLV-1 in CSF of patients with HAM/TSP
por: Enose-Akahata, Yoshimi, et al.
Publicado: (2014)

HTLV-1 proviral load of HAM/TSP patients according to new diagnostic criteria of HAM/TSP
por: Grassi, Maria F R, et al.
Publicado: (2011)

Clinical trial of raltegravir, an integrase inhibitor, in HAM/TSP
por: Enose‐Akahata, Yoshimi, et al.
Publicado: (2021)

Proteomic profiles among asymptomatic HTLV-1 carriers and HAM/TSP patients in Peru
por: Temoche, Morayma, et al.
Publicado: (2014)

HTLV-1 HBZ Protein Resides Exclusively in the Cytoplasm of Infected Cells in Asymptomatic Carriers and HAM/TSP Patients
por: Forlani, Greta, et al.
Publicado: (2019)

Recent epidemiologic trends of HAM/TSP in Japan
por: Matsuzaki, Toshio, et al.
Publicado: (2011)

HTLV-1 epigenetic modification of the FoxP3 TSDR in HAM/TSP decreases the functional proliferative suppression of Tregs
por: Anderson, Monique R, et al.
Publicado: (2014)

Integration site analysis in Japanese HTLV-1 infected asymptomatic carriers and HAM/TSP patients
por: Niederer, Heather, et al.
Publicado: (2014)

HTLV-1 proviral integration sites differ between asymptomatic carriers and patients with HAM/TSP
por: Niederer, Heather A, et al.
Publicado: (2014)

Immunophenotypic analysis of cerebrospinal fluid reveals concurrent development of ATL in the CNS of a HAM/TSP patient
por: Takeda, Reina, et al.
Publicado: (2020)

Clinical subtype of HAM/TSP based on clinical course and laboratory findings
por: Yamano, Yoshihisa, et al.
Publicado: (2011)

Evaluation of interleukin-32 and cyclooxygenase-2 expression in HAM/TSP patients and HTLV-1 asymptomatic carriers
por: Hatatian, Niayesh, et al.
Publicado: (2021)

A NKG2D Thr72Ala polymorphism is not associated with HAM/TSP and proviral load values in Peruvian HTLV-1 infected patients with HAM/TSP and asymptomatic carriers
por: Bernia, Cynthia, et al.
Publicado: (2015)

B cell costimulatory molecules as potential biomarkers in HAM/TSP
por: Menezes, Soraya M, et al.
Publicado: (2011)

HAM/TSP introduction: systematic review of HAM/TSP clinical trials
por: Anderson, Rebecca, et al.
Publicado: (2014)

Comparison of HTLV-I Proviral Load in Adult T Cell Leukemia/Lymphoma (ATL), HTLV-I-Associated Myelopathy (HAM-TSP) and Healthy Carriers
por: Akbarin, Mohammad Mehdi, et al.
Publicado: (2013)

High HTLV-I proviral load in patients with HAM/TSP and ATLL but not with other disorders
por: Altamirano, Natalia, et al.
Publicado: (2011)

Clinical trial of a humanized anti‐IL‐2/IL‐15 receptor β chain in HAM/TSP
por: Enose‐Akahata, Yoshimi, et al.
Publicado: (2019)

Gene expression and glycan profiling of CD4+T cells in HAM/TSP
por: Kodama, Daisuke, et al.
Publicado: (2011)

Neurological manifestations in HTLV-1 patients with overactive bladder syndrome. A precursor of HAM/TSP?
por: Costa, Davi, et al.
Publicado: (2011)

An interferon signature is associated with HAM/TSP but not viral containment in HTLV-1 infection
por: Tattermusch, Sonja, et al.
Publicado: (2011)

Vestibulospinal tract dysfunction in HTLV-1-asymptomatic infection and in HAM/TSP
por: Labanca, Ludimila, et al.
Publicado: (2014)

Differential expression in genes involved in the NF-κβ pathway among asymptomatic HTLV-1 carriers and HAM/TSP patients in Peru
por: Talledo, Michael, et al.
Publicado: (2014)

Managing HAM/TSP with Fampridine
por: Menna-Barreto, M Marcio
Publicado: (2014)

Clinical trial of a humanized monoclonal anti-IL15Rβ (CD122), in HTLV-1 associated myelopathy/ tropical spastic paraparesis (HAM/TSP)
por: Massoud, Raya, et al.
Publicado: (2014)

HTLV-1 proviral load as an indicative marker of HAM/TSP: a systematic review of studies of patients with HAM/TSP
por: Bassi, Shiva Shaan, et al.
Publicado: (2014)

Clinical features of familial HAM/TSP
por: Nozuma, Satoshi, et al.
Publicado: (2014)

Exacerbated inflammatory cellular immune response characteristics of HAM/TSP is observed in a large proportion of HTLV-I asymptomatic carriers
por: Santos, Silvane Braga, et al.
Publicado: (2004)

The plasticity of HTLV-1 infected CD4+CD25+CCR4+ T-cells through HTLV-1 tax in HAM/TSP
por: Araya, Natsumi, et al.
Publicado: (2011)

CD64 as a biomarker and therapeutic target in HAM/TSP and HTLV-1-associated Infective Dermatitis
por: Khouri, Ricardo, et al.
Publicado: (2011)

Evaluation of clinical outcome measures for HAM/TSP
por: Kikuchi, Takayuki, et al.
Publicado: (2015)

HAM/TSP and major depression: the role of age
por: Boa-Sorte, Ney, et al.
Publicado: (2015)

Early diagnosis of HTLV-1-associated myelopathy (HAM/TSP) in HTLV-1 carrier clinic
por: Matsuzaki, Toshio, et al.
Publicado: (2014)

Ascorbic acid has superior antiviral and antiproliferative effects over IFN-alpha in HAM/TSP PBMC ex vivo
por: Moens, Britta, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_kn6p0uv218imffmn72ut8slj55